Pilot-testing the Effect of Magnetic Mitohormesis Therapy for Treating Frailty in Older Adults
- Disease/Condition
- Frailty
- Drug/Device/Intervention
- Magnetic Mitohormesis Therapy
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Auburn University
- Location
- Auburn, United States of America
- Phase
- N/A
- Start date
- Apr 26, 2023
- End date
- Dec 30, 2024
- Enrollment
- 30 participants
Rate of adherence to intervention,Number of sites successfully recruited,Likert scale assessment of protocol implementation,Likert scale assessment of participant satisfaction
Thirty (30) adults with limited physical function will be recruited to participate in a
 double-blind pilot randomized controlled crossover trial in which all participants will
 receive 12-weeks of twice weekly MMT treatment in the first (Phase 1) or second half (Phase
 2) of the study period; during the control period, participants will receive sham treatment
 and will be blinded to the randomization.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05930470
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05930470 through Pure Global AI's free database. This phase not specified trial is sponsored by Auburn University and is currently Recruiting. The study focuses on Frailty. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.